Description
BOLDAMAXX contains Boldenone Undecylenate. Scientists originally developed this anabolic steroid as a long-acting form of Methandrostenolone (Dianabol). The substance eventually became its own distinct compound. It features a very different pharmacological profile. Veterinary medicine recognizes Boldenone Undecylenate as Equipoise. Researchers study the compound for human clinical applications.
What makes BOLDAMAXX stand out is Boldenone’s relatively balanced anabolic-to-androgenic ratio, its moderate and gradual action, and its mild estrogenic activity. Users of pharmaceutical Boldenone in clinical research contexts often note its slow, steady impact — a result of the Undecylenate ester, which gives it one of the longest half-lives among common anabolic compounds (approximately 14 days).
BOLDAMAXX by Evolve Biolabs is available through GlobalPharmaHub.com in 30, 60, and 90 ampoule packs, making it accessible for bulk pharmaceutical buyers, licensed clinics, and research institutions. It is one of the more premium products in the GlobalPharmaHub steroid range, reflecting its compound’s longer cycle requirements and higher per-unit dosing standards.
All use of BOLDAMAXX must comply with local law and be supervised by a licensed medical professional.
Key Features
- Active Ingredient: Boldenone Undecylenate
- Form: Injectable Ampoules (oil-based)
- Pack Sizes Available: 30, 60, 90 Ampoules
- Brand: Evolve Biolabs
- Ester Half-Life: Approx. 14 days (very long-acting)
- Androgenic/Anabolic Profile: Moderate and balanced
- Estrogenic Activity: Mild aromatization (less than testosterone)
- Administration Route: Intramuscular injection
Potential Benefits
- Gradual, sustained release over approximately two weeks per injection
- Mild estrogenic activity — lower risk of estrogen-related side effects compared to testosterone
- Stimulates appetite, which may be clinically useful in wasting conditions
- Supports lean tissue development with minimal fluid accumulation
- May significantly enhance red blood cell production (increased erythropoiesis)
- Well-tolerated over longer supervised clinical protocols
- Balanced anabolic-to-androgenic ratio allows for clinical flexibility
How It Is Used
Administer BOLDAMAXX via intramuscular injection.
Schedule injections once per week due to the long ester half-life.
Oil-based formulations like Boldenone Undecylenate provide more comfort than aqueous suspensions.
Clean and swab the injection site properly.
Rotate injection sites between locations.
Clinical and research contexts utilize longer cycle lengths of 12–16 weeks.
The slow-building nature of the compound requires extended durations.
Medical supervision and regular bloodwork remain essential throughout use.
Possible Side Effects
- Mild to moderate estrogenic effects (some water retention is possible)
- Testosterone suppression
- Increased appetite — may be undesirable in some patients
- Elevated red blood cell count / hematocrit — requires monitoring
- Androgenic effects: acne, oily skin, possible hair loss in susceptible individuals
- Virilization risk in females
- Injection site discomfort (mild — oil-based formulation is generally well-tolerated)
- Lipid profile alterations
Storage Instructions
- Store at room temperature (15°C–30°C / 59°F–86°F)
- Do not refrigerate or freeze (oil-based solutions may crystallize)
- Keep away from direct sunlight and heat
- Store in original sealed ampoules
- Keep out of reach of children
- Check ampoule integrity before use — do not use if visibly contaminated or cracked
- Follow local medical waste disposal regulations for used ampoules
